The Central Administrative Tribunal (CAT) has overturned the transfer of Indian Revenue Service (IRS) officer Sameer Wankhede from Mumbai to Chennai, ruling that the revenue department violated its own guidelines. Wankhede, known for his role in the Cordelia cruise drug bust case involving Bollywood actor Shah Rukh Khan's son, had claimed his transfer was punitive and a consequence of his actions at the Narcotics Control Bureau (NCB). The CAT found procedural lapses and potential bias in the transfer decision, stating that transfer policies must be implemented fairly and transparently.
In a victory for Indian drug companies, patent protection has been refused to Tenofovir, an anti-AIDS medicine of the US-based Gilead Sciences. The decision was taken by the patent office in New Delhi.
The Indian Army on Thursday said it has registered the intellectual property rights of its new design and camouflage pattern uniform.
Roche has already adapted its business model in India to increase affordable access to drugs and try to stave off trouble from India's patent authorities.
The patent department made this declaration on August 16 after Novartis had failed to respond to its queries within the prescribed time.
The European Patent Office has upheld the revocation of a patent on the Indian 'neem' tree, dealing a killer blow to biopiracy in Europe and around the world.\n\n
The United Kingdom extracted USD 64.82 trillion from India over a century of colonialism between 1765 and 1900 and USD 33.8 trillion of this went to the richest 10 per cent -- enough money to carpet London in notes of 50 British pound almost four times over.
First time, an Indian court revisits a patent office order.
The European Patent Office (EPO) has rejected 15 patent applications of various international companies during the past one year after it found they had used India's traditional medicinal knowledge to prepare certain products.
The domestic pharmaceutical industry and non-government organisations are up in arms against the first ever Indo-US tie-up on intellectual property rights
Kamal has a crisp pen when it comes to writing short and yet powerful film dialogues. But while speaking ex tempore -- and that has been his style -- he looks every bit a confused man, observes N Sathiya Moorthy.
India rejects patent on Pfizer's arthritis drug
Firm says the proposed drones can also be used to identify other such objects, along with aircraft, plying within Indian skies
I'...additional concessions, such as opening government procurement, reducing agricultural subsidies, weakening patent protections, and allowing unrestricted data flows -- demands India has resisted for decades.'
Both firms have made several applications for patents pertaining to digital payments in the country
China has consistently spent more than 2% of GDP on R&D while India's expenditure on R&D has stagnated around 0.7% of GDP. Can our government shore up resources so that we hit the R&D expenditure target of 2% of GDP set out by the Science, Technology and Innovation Policy of 2013, asks Chidambaran G Iyer, Senior Fellow, Pahle India Foundation.
Indian cos or academic institutions accounted for only 1,394 patent cooperation treaty applications
'Presumption of innocence must guide all formal actions, but transparency must not be mistaken for pre-judgment.' 'The cruel irony, however, is that Justice Varma is a fine judge who enjoys a reputation for writing well-reasoned judgments.'
Several Indian units of American technology companies have filed more than 1,000 patent applications with the US Patent and Trademark office, a media report said on Tuesday.
'It is our duty to keep space sustainable and free of debris.'
'Mankind's experience, sharpness, and execution will make it happen. We are not going for short-term gains.'
Company claims new use for kala jeera extract, provoking alarmed campaigners here and abroad; says reaction not based on facts.
Delegation visit ahead of patent law report.
The US on Thursday raised concerns over India's Personal Data Protection (PDP) Bill and draft non-personal data governance framework, claiming these could potentially threaten innovation and economic growth. In its latest 'Special 301' Report, the US Trade Representative (USTR) kept India on the priority watch list, maintaining the country remains one of the world's most challenging major economies with respect to protection and enforcement of intellectual property (IP). In December 2021, a joint parliamentary committee released a report recommending changes to the PDP Bill, 2019, that could undermine important IP protections in India.
India's IPR framework and enforcement were comparable to those in developed countries
A federal body began a hearing on the impact of Indian trade policies on US businesses wherein American bodies and advocacy groups slammed India for its trade practices, alleging they hit their jobs and business.
India has also become the fourth best represented nation in the 2024 rankings, up from sixth last year.
Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up.
Flash Electronics alleges Royal Enfield infringed its patent on regulator rectifier device.
For now, Modi's government appears singularly focussed on demonstrating that it is not in any way inhibited by the BJP's loss of a majority, and will continue along its patented path of bulldozing all opposition and doing just as it likes, asserts Prem Panicker.
Throughout its 155 minutes, every scene is doused in blaring background music and melodrama. Disappointment alone won't do, it must feel like a full blown catastrophe, observes Sukanya Verma.
The strong IPR protection across the board -- patents, trademark and copyright - had been a lynchpin in the success of the US services sector, he added.
'Even for operational buildings, we are looking to smarten them in various ways.'
The CBI, in its FIR, alleged that Mayaram, the UK-based company De La Rue International Ltd and unidentified officials of the finance ministry and RBI hatched a criminal conspiracy to extend undue favour to the firm.
Among the companies likely to sign deals with Gilead are Cadila, Hetero, Strides Arcolab and Mylan, while Cipla is expected to earn active pharmaceutical ingredient rights.
In the technology (tech) world, especially storage, Sanjay Mehrotra is a well-known name. Co-founder of SanDisk, a flash memory storage company in 1988, it was eventually acquired by Western Digital in 2016 for a whopping $19 billion. For a boy from Kanpur, who went on to pursue higher studies in the US, becoming the chief executive officer of Micron Technology, Inc - one of America's largest memory chip makers - and now setting up the company's first plant in India, it has been quite a ride.
'However, we have seen weakness in our active pharmaceutical ingredients business.'
The government has also set targets for the next 25 years. We are working on the target of becoming a $5-10 trillion economy as well as taking exports to a record high, he said.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances